Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,406
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: St Louis MO, Creve Coeur MO, Chesterfield MO, Shiloh IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT04803201
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: St Louis MO, Florissant MO, Creve Coeur MO, Shiloh IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: St Louis MO, Creve Coeur MO, O'Fallon IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 60+
Code: NCT07437950
Phase 2, Recruiting
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
for
Recurrent Plasmablastic Lymphoma,
Location: St Louis MO, Creve Coeur MO, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07332507
Phase 1, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: St Louis MO, City of Saint Peters MO, Macomb IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: St Louis MO, Nashville TN, Fairfax VA, Austin TX,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase 1, Recruiting
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
for
Small Cell Lung Cancer, Renal Cell Carcinoma (RCC),
Location: St Louis MO, Birmingham AL, Cleveland OH
Sponsor: Advenchen Pharmaceuticals, LLC.
Sex: All
Age: 18+
Code: NCT05363280
Phase 2, Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
for
Solid Tumours
Location: St Louis MO, Houston TX, Fairfax VA, Philadelphia PA,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT06725758
Phase 1, Phase 2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: St Louis MO, Florissant MO, Creve Coeur MO, Shiloh IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: St Louis MO, Springfield MO, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: St Louis MO, Rochester MN, Jacksonville FL,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT07450859
Phase 2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: St Louis MO, Creve Coeur MO, Shiloh IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: St Louis MO, Creve Coeur MO, Shiloh IL,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: St Louis MO, Creve Coeur MO, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: St Louis MO, Iowa City IA, Nashville TN, Chicago IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: St Louis MO, Creve Coeur MO, O'Fallon IL, Shiloh IL,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase 3, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: St Louis MO, Creve Coeur MO, O'Fallon IL, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06524544
Phase 3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer